{Reference Type}: Journal Article
{Title}: Congenital diaphragmatic hernia treated via fetal endoscopic tracheal occlusion improves outcome in a middle-income country.
{Author}: Manfroi A;Bernardes LS;de Oliveira LMC;Peres SV;de Carvalho WB;Tannuri ACA;da Silva MM;Del Bigio JZ;de Amorim Filho AG;de Carvalho MHB;de Francisco RPV;Carvalho MA;
{Journal}: J Perinat Med
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jun 27
{Factor}: 2.716
{DOI}: 10.1515/jpm-2024-0070
{Abstract}: <B>OBJECTIVE: </B>A recent European randomized trial - Tracheal Occlusion To Accelerate Lung Growth - demonstrated that fetoscopic endoluminal tracheal occlusion (FETO) is associated with increased postnatal survival among infants with severe congenital diaphragmatic hernia (CDH). However, this differs in middle-income countries such as Brazil, where abortion is illegal and neonatal intensive care is inadequate. This study evaluated the effects of FETO on improving the survival of infants with moderate-to-severe CDH in isolated and non-isolated cases.<BR><B>METHODS: </B>This retrospective cohort study selected 49 fetuses with CDH, a normal karyotype, and a lung-to-head ratio (LHR) of <1 from a single national referral center for fetal surgery in São Paulo, Brazil, between January 2016 and November 2019. FETO was performed between 26 and 29 weeks of gestation. The primary outcomes were infant survival until discharge from the neonatal intensive care unit and survival until six months of age.<BR><B>RESULTS: </B>Forty-six women with singleton fetuses having severe CDH underwent prenatal intervention with FETO. Infant survival rates until discharge and at six months of age were both 38 %. The observed-to-expected LHR increased by 25 % after FETO in neonates who survived until discharge. Spontaneous intrauterine death occurred in four growth-restricted fetuses after FETO. Preterm birth in <37 weeks and preterm rupture of membranes in <34 weeks occurred in 56.5 % (26) and 26 % (12) cases, respectively.<BR><B>CONCLUSIONS: </B>FETO may increase neonatal survival in fetuses with severe CDH, particularly in countries with limited neonatal intensive care.